PDA Visual Inspection and Particle Control in Parenteral Drug Product Manufacturing Webinar 2024
Become a Sponsor and/or Exhibitor
Registration Options
Individual Registration
Group Registration
Welcome to the PDA Visual Inspection and Particle Control in Parenteral Drug Product Manufacturing Webinar 2024, co-organized by Clear Solutions Laboratories!
Visual inspection of parenteral drug products is a critical aspect of pharmaceutical development and manufacturing, subject to evolving regulatory standards. This webinar brings together experts to address the complex landscape of particle visibility and regulatory compliance, with a focus on enhancing product quality and patient safety. The webinar will provide attendees with a holistic view of the challenges, innovations, and best practices in visual inspection, offering an overview of the regulatory and compendial environment for visual inspection.
An exceptional lineup of speakers will accompany the webinar:
- Antonio Burazer, Takeda
- Atanas Koulov, Clear Solutions Laboratories
- John Shabushnig, Insight Pharma Consulting
- Rukman De Silva, U.S. FDA
A Q&A session will provide an interactive platform to address your queries after the talks. This is an excellent opportunity to learn from some of the leading experts in the field. We encourage you to register for the event and actively contribute to the Q&A session to share your knowledge and expertise with industry experts.
Highlighted Presenters
Key Presenters
Agenda
Discover What's Happening Each Day
Tuesday, 29 October 2024
Moderator: Roman Mathaes, Clear Solutions Laboratories
First Presentation: Industry Best Practices in Life Cycle & Risk Management for Visible Particles in Parenterals
Antonio Burazer, Takeda
Beyond the Obvious: Defect Detectability and Impact on Visual Inspection Qualification
Atanas Koulov, Clear Solutions Laboratories
Third Presentation: The Visual Inspection Regulatory and Compendial Environment: Current Issues and Opportunities
John Shabushnig, Insight Pharma Consulting
Fourth Presentation: Current Regulatory Considerations for the Assessment of Visible Particulates in Injectable Pharmaceuticals
Rukman De Silva, U.S. FDA
Q&A, Discussion
Registration
Pricing Options
Standard Registration
Member Price
€ 0Non-Member
€ 0
ALL PRICES IN EURO (EUR), EXCLUDING VAT.
WAYS TO REGISTER: 1. Online Registration 2. registration-europe@pda.org
PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact registration-europe@pda.org before registering.
If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.
Presenters
Meet the Experts
Sponsors
Sponsors and Collaborators
Become a Sponsor and/or Exhibitor
Amplify Your Presence and Reach Your Customers!
Become a Sponsor
Elevate your brand and maximize your exposure by becoming a sponsor at the PDA Visual Inspection and Particle Control in Parenteral Drug Product Manufacturing Webinar 2024! Connect with industry leaders, showcase your products and services, and establish your company as a key player in the field.
Request InformationBecome an Exhibitor
Boost your brand and visibility by becoming an exhibitor at the PDA Visual Inspection and Particle Control in Parenteral Drug Product Manufacturing Webinar 2024! Connect with industry influencers, showcase your products and services, and position your company as a key player in the field.
Request InformationHave a question or need assistance?
Send us a message, and our team will get back to you shortly. We're here to help!